Pushkal Garg is VP at ALNYLAM PHARMACEUTICALS, INC. (ALNY). They have made 13 open-market trades across 1 company since 2023, most recently 2026-03-05.
CIK 0001829252
Unrated. We grade insiders only on stock they chose to buy on the open market. Grants, option exercises and vesting say nothing about timing, so they don't count — which is why someone can file often and still have no grade. It isn't a bad sign: unrated buys beat every graded tier below A.
0 open-market purchases, against 13 sales. Too few scored purchases to measure a record yet.
| Ticker | Shares | Value |
|---|---|---|
| ALNY | 18,693 | $4.3M |
Shares reported on the most recent Form 4, priced at the 2026-03-06 close.
Counted per filing, not per execution lot — a purchase filled in several tranches is one decision.
| Ticker | Type | Traded | Filed | Price | Value | 7d Stock | 30d Stock | 90d Stock |
|---|---|---|---|---|---|---|---|---|
| ALNY | SELL | 2026-03-04 | 2026-03-06 | $323.53 | $1.5M | -0.8% | +4.1% | -4.3% |
| ALNY | SELL | 2026-03-02 | 2026-03-04 | $323.63 | $1.1M | -1.5% | +2.1% | -11.6% |
| ALNY | SELL | 2026-02-27 | 2026-03-02 | $331.34 | $1.5M | -1.3% | +2.3% | -8.2% |
| ALNY | SELL | 2026-02-13 | 2026-02-17 | $310.08 | $695K | +1.2% | -5.4% | -13.0% |
| ALNY | SELL | 2026-01-12 | 2026-01-14 | $362.87 | $548K | -3.7% | -14.7% | -7.9% |
| ALNY | SELL · 10b5-1 | 2025-10-02 | 2025-10-03 | $451.76 | $5.3M | +2.5% | -5.4% | -12.8% |
| ALNY | SELL · 10b5-1 | 2025-08-18 | 2025-08-19 | $456.11 | $2.5M | -2.8% | -1.6% | +0.3% |
| ALNY | SELL · 10b5-1 | 2025-03-21 | 2025-03-25 | $293.36 | $2.9M | -15.8% | -13.4% | +11.8% |
| ALNY | SELL · 10b5-1 | 2025-03-03 | 2025-03-05 | $242.88 | $1.0M | +3.5% | -3.6% | +24.2% |
| ALNY | SELL | 2025-02-28 | 2025-03-03 | $241.89 | $311K | +0.3% | +10.7% | +27.0% |
| ALNY | SELL · 10b5-1 | 2025-02-14 | 2025-02-18 | $252.71 | $1.3M | -1.4% | +1.3% | +16.7% |
| ALNY | SELL · 10b5-1 | 2025-01-27 | 2025-01-29 | $285.00 | $15.0M | -0.3% | -10.2% | -6.4% |
| ALNY | SELL · 10b5-1 | 2024-12-12 | 2024-12-13 | $251.05 | $742K | -1.6% | +4.8% | -1.9% |
| ALNY | SELL | 2024-11-26 | 2024-11-27 | $250.97 | $812K | +1.3% | -5.0% | -2.2% |
| ALNY | SELL | 2024-06-25 | 2024-06-26 | $231.31 | $831K | +4.0% | -4.1% | +10.6% |
| ALNY | SELL | 2024-02-28 | 2024-02-29 | $155.30 | $89K | -2.8% | +1.6% | -2.6% |
| ALNY | SELL | 2024-02-16 | 2024-02-20 | $148.12 | $293K | +1.5% | -2.5% | -0.0% |
| ALNY | SELL | 2023-08-04 | 2023-08-07 | $184.70 | $2.7M | -0.4% | +9.2% | -9.4% |
| ALNY | SELL | 2023-04-27 | 2023-04-28 | $197.54 | $1.4M | +6.1% | -6.2% | -2.0% |
| ALNY | SELL | 2023-03-03 | 2023-03-07 | $200.00 | $3.6M | -4.3% | +8.9% | -0.7% |
Grouped by shared companies and similar filing behaviour. This is a similarity measure, not a ranking or a performance signal.